This invention involves compounds having the following structure:
1
as described in the Claims; and enantiomers, optical isomers, stereoisomers, diastereomers, tautomers, addition salts, biohydrolyzable amides and esters thereof, as well as pharmaceutical compositions comprising such novel compounds. The invention also relates to the use of such compounds for preventing or treating disorders modulated by alpha-2 adrenoceptors.
本发明涉及具有以下结构的化合物:1,如权利要求所述; 以及其对映体,光学异构体,立体异构体,对映异构体,互变异构体,加成盐,
生物水解酰胺和酯,以及包括这种新化合物的药物组合物。该发明还涉及使用这些化合物预防或治疗受α-2
肾上腺素受体调节的疾病。